Executive Vice President, Chief Financial Officer

Executive Vice President, Head of Development

Stoke Therapeutics stock falls after delayed Phase 3 readout timeline

Ionis well-positioned for continued momentum and substantial value creation in 2026 with two new independent launches and several pivotal data readouts

Proximity Health Solutions and Biogen Named Finalists for the SCOPE '26 Participant Engagement Award

Biogen, Eisai Say China Accepts Application for Subcutaneous Formulation of Early Alzheimer's Disease Treatment

Director, CMC Asset Lead

Biogen is a global biotechnology company committed to delivering life-changing medicines. The CMC Asset Lead will provide cross-functional leadership for development programs, overseeing all aspects of asset strategy, development, supply, and lifecycle management for CMC components of clinical programs.

Director, Cmc Asset Lead in united states (1000+)

Director, CMC Asset Lead